Clinical Trials · NCT06145308
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Peking Union Medical College
- Enrollment
- 39
- Start date
- Aug 2023
- Locations
- 2 sites, China
- Primary endpoint
- ORR